NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Blanka Halamoda-Kenzaoui, Simon Baconnier, Thierry Bastogne, Didier Bazile, Patrick Boisseau, Gerrit Borchard, Sven E. Borgos, Luigi Calzolai, Karin Cederbrant, Gabriella di Felice, Tiziana Di Francesco, Marina Dobrovolskaia, Rog?rio Gaspar, Bel?n Gracia, Vincent A. Hackley, Lada Leyens, Neill Liptrott, Margriet Park, Anil Patri, Gert Roebben, Matthias Roesslein, Ren? Th?rmer, Patricia Urb?n L?pez, Val?rie Zuang, Susanne Bremer-Hoffmann
Abstract
The workshop "Bridging communities in the field of nanomedicine" was hosted by the European Commission Joint Research Centre on 27-28 September 2017. It gathered experts from regulatory bodies, research institutions and industry to discuss the main challenges related to the emerging field of nanomedicine. Regulatory aspects and standardisation needs were discussed. The major criteria and gaps in existing methodologies for the regulatory application were identified. The workshop discussions, documented in this manuscript, helped to formulate critical recommendations for the development of the most needed methods and standards to be addressed e.g. in ongoing Horizon 2020 projects. In addition, individual opinions of experts relevant to progress of the regulatory science in the field of nanomedicine were summarized in the format of a survey.
Halamoda-Kenzaoui, B.
, Baconnier, S.
, Bastogne, T.
, Bazile, D.
, Boisseau, P.
, Borchard, G.
, Borgos, S.
, Calzolai, L.
, Cederbrant, K.
, di Felice, G.
, Di Francesco, T.
, Dobrovolskaia, M.
, Gaspar, R.
, Gracia, B.
, Hackley, V.
, Leyens, L.
, Liptrott, N.
, Park, M.
, Patri, A.
, Roebben, G.
, Roesslein, M.
, Th?rmer, R.
, Urb?n L?pez, P.
, Zuang, V.
and Bremer-Hoffmann, S.
(2019),
Bridging communities in the field of nanomedicine, Regulatory Toxicology and Pharmacology, [online], https://doi.org/10.1016/j.yrtph.2019.04.011, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=926952
(Accessed October 13, 2025)